(Q54487686)

30 May 2018

title

Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. (English)

1 reference

30 May 2018

0 references

3

1 reference

30 May 2018

Roberto Coppola

16

1 reference

30 May 2018

Vito Michele Fazio

17

1 reference

30 May 2018

Mariangela De Robertis

Mariangela De Robertis

5

0 references

Damiano Caputo

Damiano Caputo

13

0 references

Marco Caricato

Marco Caricato

14

0 references

Giuseppe Perrone

Giuseppe Perrone

8

0 references

Andrea Onetti Muda

Andrea Onetti Muda

9

0 references

Massimiliano Copetti

Massimiliano Copetti

6

0 references

author name string

Maria Luana Poeta

1

1 reference

30 May 2018

Emanuela Massi

2

1 reference

30 May 2018

Pasquale Pellegrini

4

1 reference

30 May 2018

Carla Rabitti

7

1 reference

30 May 2018

Francesca Molinari

10

1 reference

30 May 2018

Elena Zanellato

11

1 reference

30 May 2018

Stefano Crippa

12

1 reference

30 May 2018

Milo Frattini

15

1 reference

30 May 2018

publication date

25 August 2012

1 reference

30 May 2018

Genes, Chromosomes and Cancer

published in

1 reference

30 May 2018

volume

51

1 reference

30 May 2018

issue

12

1 reference

30 May 2018

page(s)

1133-1143

1 reference

30 May 2018

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression

cites work

1 reference

Glycomics and disease markers

21 January 2018

1 reference

Growth retardation and early death of beta-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells

21 January 2018

1 reference

Epigenetic gene regulation in cancer

21 January 2018

1 reference

Worldwide variations in colorectal cancer

21 January 2018

1 reference

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

21 January 2018

1 reference

Recent patents of DNA methylation biomarkers in gastrointestinal oncology

21 January 2018

1 reference

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors

21 January 2018

1 reference

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

21 January 2018

1 reference

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

The epigenetic progenitor origin of human cancer

21 January 2018

1 reference

Different genetic features associated with colon and rectal carcinogenesis.

21 January 2018

1 reference

Beta-1,4-galactosylation of N-glycans is a complex process

21 January 2018

1 reference

Genetic and epigenetic alterations in colon cancer

21 January 2018

1 reference

Glycosylation defining cancer malignancy: new wine in an old bottle

21 January 2018

1 reference

Glycomics hits the big time

21 January 2018

1 reference

Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis

21 January 2018

1 reference

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

21 January 2018

1 reference

Genome-wide promoter analysis uncovers portions of the cancer methylome.

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2010

1 reference

21 January 2018

Global cancer statistics

1 reference

The epigenomics of cancer

21 January 2018

1 reference

Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants--Hakomori's concepts revisited

21 January 2018

1 reference

Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.

21 January 2018

1 reference

DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer

21 January 2018

1 reference

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer

21 January 2018

1 reference

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

21 January 2018

1 reference

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

21 January 2018

1 reference

Epigenetic gene regulation in stem cells and correlation to cancer

21 January 2018

1 reference

Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

21 January 2018

1 reference

Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR

21 January 2018

1 reference

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

21 January 2018

1 reference

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens

21 January 2018

1 reference

American Cancer Society guidelines for the early detection of cancer, 2006.

21 January 2018

1 reference

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening

21 January 2018

1 reference

Cancer epigenetics: linking basic biology to clinical medicine.

21 January 2018

1 reference

Colorectal cancer epigenetics: complex simplicity

21 January 2018

1 reference

Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations

21 January 2018

1 reference

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

Epigenetic codes in stem cells and cancer stem cells

21 January 2018

1 reference

Constitutively active PKB/Akt inhibited apoptosis and down-regulated beta1,4-galactosyltransferase 1 in hepatocarcinoma cells.

21 January 2018

1 reference

Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.

21 January 2018

1 reference

Highly methylated genes in colorectal neoplasia: implications for screening

21 January 2018

1 reference

Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia

21 January 2018

1 reference

7 January 2021

Cell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway

1 reference

7 January 2021

Are we getting closer to molecular population screening for colorectal cancer?

1 reference

7 January 2021

The use of molecular markers in the diagnosis of colorectal cancer screening

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.21998

1 reference

30 May 2018

1 reference

30 May 2018